Related Experiment Videos
Mood disorders in Parkinson's disease.
1Department of Neurology, Parkinson's Disease and Movement Disorders Centre, National Neuroscience Institute, Singapore, USA. louis_tan@nni.com.sg
Parkinsonism & Related Disorders
|December 15, 2011
Summary
Mood disorders like depression, anxiety, and apathy are common in Parkinson's disease (PD), impacting quality of life. More research is needed for effective diagnosis and evidence-based treatments for these non-motor symptoms.
Area of Science:
- Neurology
- Psychiatry
Background:
- Non-motor features of Parkinson's disease (PD) are increasingly recognized.
- Mood disorders, including depression, anxiety, and apathy, are prevalent in PD, affecting quality of life and daily function.
- These symptoms can manifest early and may even precede motor symptom onset.
Purpose of the Study:
- To review the epidemiology, clinical features, diagnosis, and management of depression, anxiety, and apathy in Parkinson's disease.
- To highlight challenges in diagnosing these mood disorders due to overlapping symptoms with PD.
- To identify gaps in current management strategies and emphasize the need for evidence-based treatments.
Main Methods:
- Literature review focusing on mood disorders in Parkinson's disease.
- Analysis of epidemiological data, clinical presentations, diagnostic challenges, and treatment approaches.
- Identification of areas requiring further research and development of diagnostic criteria and therapeutic interventions.
Main Results:
- Depression, anxiety, and apathy are common and impactful non-motor symptoms in PD.
- Diagnosis is challenging due to symptom overlap with PD motor features.
- Limited empirical evidence exists for current treatment strategies.
Conclusions:
- Accurate diagnosis and effective management of mood disorders in PD are critical.
- Development of validated diagnostic criteria and rating scales for anxiety and apathy in PD is a priority.
- There is an urgent need for systematic studies on pharmacological and non-pharmacological treatments to support an evidence-based approach to managing mood disorders in PD.
Related Concept Videos
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.